MENODYS announces the signing of an exclusive worldwide licence on a wound care treatment device

Montreal, Quebec, Canada – MENODYS and the Office of Sponsored Research, McGill’s commercialization group, have agreed to the terms of an exclusive worldwide licence to a medical device developed by Prof. Satya Prakash, Director of Biomedical Technology and Cell Therapy Research Laboratory, Dr. Mirko Gilardino, Assistant Professor of Surgery and Cranial/Facial Plastic Surgeon, and Mr. Jonathan Kanevsky, medical student, all of whom are associated with McGill University. This technological innovation, already protected under a provisional patent, aims at reducing and improving the appearance of dermatological scars, including minimizing the development of hypertrophic scars.


MENODYS is a Canadian company specialized in the development and commercialization of medical technologies.

About McGill

Founded in Montreal, Quebec, in 1821, McGill is Canada’s leading university, with two campuses, 11 faculties, 11 professional schools, 300 programs and more than 37,000 students, including 8,300 at the graduate level. McGill welcomes students from more than 150 countries, with 7,200 foreign students making up 20 per cent of the student body. For further information, go to: